Vol. 2, Issue 3, / July-September 2001
(Original Article, pages 4-12)

Iraj Amiri Corresponding Author
1- Anatomy Department, Faculty of Medicine, Tehran Medical Sciences University, Tehran, Iran
2- Anatomy Department, Faculty of Medicine, Hamedan Medical Sciences University, Tehran, Iran
Hasan Marzban
- Anatomy Department, Faculty of Medicine, Tehran Medical Sciences University, Tehran, Iran
Mohammad Barbarestani
- Anatomy Department, Faculty of Medicine, Tehran Medical Sciences University, Tehran, Iran
Seyed Noureddin Nematollahi-Mahani
- Professor, Anatomy Department, Faculty of Medicine, Kerman Medical Sciences University, Kerman, Iran

Received: 3/7/2001 Accepted: 8/2/2001 - Publisher : Avicenna Research Institute

Related Articles


Other Format



It is accepted that maternal hyperglycemia causes delay in early embryonic development, spontaneous miscarriage & malformations. According to various studies, some of these problems occur in earlier stages of embryonic developmen especially pre-implantation stage. It seems that elevated glucose level of blood can have important role in this regard as potential teratogen factor. One of cases, which can be related to racousnesses resulting from glucose effects is Nitric Oxide (NO) system disorder in hyperglycemic condition. Some evidences show at first in hyperglycemic condition, L-arginine uptake of media by embryo increases and therefore leads to decrease amount of available L-arginine and since L-arginine is essential substrate for NO production, so it’s decrease inhibits NO production. To examine this hypothesis, 2-cell embryos of mice were cultured in media of high concentration of glucose (30mM) and different concentrations of L-arginine (5, 10, 20 mM) and their growth and development were assessed and at the end, embryos were stained by Hoechst 33254 color and the number of their blactocysts were counted by use a Fluorescence microscope. Comparison of embryos culture in HTF culture media with different concentration of glucose and L-arginin showed in high glucose media up to 30 mM affects growth and development of embryos totally and decrease their blactocysts numbers, but addition of 5–10 mM L-arginine to this media significantly improves this condition. On the contrary addition of L-NAME (an antagonist of L-arginine) significantly inhibits the development of pre-implantation embryos. It seems that reduction in NO production in diabetes is due to decreases in amount of available L-arginine, because increase in L-arginine concentration in high glucose media up to 10 mM partially improves high glucose embryo toxicity. Base on acquired result, it seems use of L-arginine or material which cause NO release in media, can have important role in prevention of high glucosis embryo toxicity.

Keywords: Glucose, Pre-implantation, Embryo, Diabetes, L-arginine, Nitric oxide

To cite this article:


  1. Richard G., Mccrecken E.J. Disturbed development of the pre implantation embryos in the insulin–depedent diabetic BB/E rats. Diabetes. 1996; 1463-70.
  2. Wercheval M., Hertogh R. Experimental diabetes rat embryo development during the pre-implantation period. Diabetologia. 1990; 33: 187-91.
  3. Pamfer S., Hertogh R., Vanderhyden I. Increased inner cell mass proportion in blastocyst diabetes. 1990; (39): 471-976.
  4. Mill S. Lack of relation of increased malformation in infants of diabetic mother to glycemic control during organogenesis. New Eng J Med. 1998; 318: 671-9.
  5. Hertogh R., Vercheval M., Pamfer S. Experimental diabetes interference with the early development of rat embryo in the pre-implantation period. Diabetologia. 1989; 32: 480A.
  6. Moley K.H., Chi M.Y., Knudson C.M. Hyperglycemia induces apoptosis in pre-implantation embryos through call death effector pathways. Nature Med. 1998; 4(12): 1421-4.
  7. Pamfer S., Vsnderhyden I., Mccracken E.J. Increased cell death in rat blastocysts exposed to maternal diabetes in utero and high glucose or tumor necrosis factor in vitro. Dev. 1997; 124: 4827-36.
  8. Beebe I., Kaye P. Maternal diabetes and retarded pre-implantation development of mice.Diabetes. 1991; 40: 457-61.
  9. Gardner D.K., Leese H.J. Concentration of nutrients in mouse oviduct fluid and their
  10. Hertogh R., Vanderheyden I., Pamfer S. Stimulatory and inhibitory effects of glucose and insulin on rat blastocysts development in vitro. Diabetes. 1991; 40: 641-7.
  11. Xialin Y., Hakanborg L., Eriksson J. Altered mitochondria morphology of rat embryos in diabetic pregnancy. Anat Rec. 1995; 241: 255-67.
  12. Gouge R., Marshburn P., Gordon B., et al. Nitric oxide as a regulatory of embryonic development. Biol Reprod. 1998; 58: 875-9.
  13. Lindsay R.M. In vivo and in vitro evidence of altered Nitric oxide metabolisms in the spountaneusly diabetic insulin BB/E rat. Br J Pharmacol. 1997; 120:1-6.
  14. Karabatus L.,Fabiano L., Bruno D. Inhabitation of Nitric oxide generation: normalization of in vitro insulin secretion in mice. Metab. 1996; 45(8): 940-6.
  15. Marina L., Morrison P. Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev. 1998; 14; 241-9.
  16. Quinn P., Kerin J., Warnes G.M. Improved pregnancy rats in human in vitro fertilization with the use of a media based on the composition of human tubal fluid. Fertil Steril. 1985; 44: 493-8.
  17. Huei W.C., Wen S.J., Chii R.T. Nitric oxide as a regulator in pre-implantation embryo development and apoptosis. Fertil Steril. 2001; 75 (6): 1163-71.
  18. Trachtman H., Futrweit S., Crimmins D. High glucose inhibits nitric oxide production in cultured rat mesangial cells. J Am Soc Nephrol. 1997; 8(8): 1276-82.
  19. Ho F., Liau C.S., Liu S.H., et al. Nitric oxide prevents apoptosis of human endothelial cells from high glucose exposure during early stage. J Cell Biochem. 1999; 75(2): 258-63.
  20. Novaro V., Gonzalez E. Nitric oxide synthasa regulation during embryonic implantation. Reprod Fertil. 1997; 9: 557-64.
  21. Joo B., Park S.H., Park S.J., et al. The effect of nitric oxide on sperm cell function and embryo development. Am J Reprod Immun. 1997; 42(6): 327-34.
  22. David A., Wink J., Cook A. Nitric oxide protects against cellular damage by ROS. Toxicol Lett. 1995; 82-3: 221-6.
  23. Yvonne E., Janssen M.W. Depletion of Nitric oxide causes cell alteration, apoptosis and oxidative stress. Am Phys Soc. 1998; 1100-8.
  24. Ornoy A., Kimyagarov D., Yaffee P., et al. Role of reactive oxygen species in diabetic induced embryo toxicity: studies on pre-implantation mouse embryos cultured in serum from diabetic pregnant women. Isr J Med Sci. 1999; 32(11): 1066-73.
  25. Oraly V. Nitric oxide and oxygen radicals: a question of balance. FEBS Letter. 1995; 396: 131-5.


Home | About Us | Current Issue | Past Issues | Submit a Manuscript | Instructions for Authors | Subscribe | Search | Contact Us

"Journal of Reproduction & Infertility" is owned, published, and managed by Avicenna Research Institute .
Creative Commons License

This work is licensed under a Creative Commons Attribution –NonCommercial 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Journal of Reproductoin and Infertility (JRI) is a member of COMMITTEE ON PUBLICATION ETHICS . Verify here .

©2024 - eISSN : 2251-676X, ISSN : 2228-5482, For any comments and questions please contact us.